Canada Spends Logo

Explore our Budget 2026 analysis

Grant: New Investigator Salary Award - PA: Drug Safety and Effectiveness - Drug Safety

University of British Columbia

$300,000.00

Validation of a Screening Strategy for Adverse Drug Reactions in the Emergency Department

FY 2011-12

Summary
Adverse drug reactions are unintended and harmful effects caused by medications. They are a common cause of preventable adverse events in medicine. In Canada, adverse drug reactions cause 720,000 Emergency Department (ED) visits each year. Adverse drug reactions are not easy to recognize. In fact, they are misdiagnosed 39-49% of the time in the ED, and the consequences can be serious. If the medication causing the problem is not stopped, the patient's condition can worsen and may even lead to death. Past attempts to develop tools to help community doctors prescribe medications in a safer manner and to help health care professionals identify and treat adverse drug reactions have not been very successful. This is because the resources required to make the diagnosis and readjust the medications are often not available in the outpatient setting. The ED is the ideal setting to address these problems. EDs have all the necessary resources, and patients with the most severe adverse drug reactions frequently go to the ED. In a previous study, we developed a user-friendly screening tool, similar to a checklist, that accurately identifies patients in the ED with adverse drug reactions. Our goal is to evaluate this screening tool on a larger scale to confirm its safety and accuracy. We propose to do this in a study enrolling 3550 patients from seven EDs in three provinces. Nurses will apply the screening tool we will evaluate, and pharmacists will assess all patients to determine who has an adverse drug reaction. We will then determine how many patients diagnosed with adverse drug reactions the screening tool has detected, how easy it is to use, how reliable it is, and what its potential impact is on clinical practice. Once we have evaluated the screening tool, we plan to roll out it out in EDs throughout Canada and internationally. We believe that this will lead to better patient care, less patient suffering and decrease the cost of health care.
Program
New Investigator Salary Award - PA: Drug Safety and Effectiveness - Drug Safety
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
241768
Name
Hohl Corinne M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Health Research Salary A
Projecttitle
Validation of a Screening Strategy for Adverse Drug Reactions in the Emergency Department
Programtype2
Salary Programs
Orgnameinp2
University of British Columbia
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
New Investigator Salary Award - PA: Drug Safety and Effectiveness - Drug Safety
Keyworddelim
Adverse Drug Related Events; Clinical Decision Rule; Emergency Medicine; Patient Safety
Abstract
Adverse drug reactions are unintended and harmful effects caused by medications. They are a common cause of preventable adverse events in medicine. In Canada, adverse drug reactions cause 720,000 Emergency Department (ED) visits each year. Adverse drug reactions are not easy to recognize. In fact, they are misdiagnosed 39-49% of the time in the ED, and the consequences can be serious. If the medication causing the problem is not stopped, the patient's condition can worsen and may even lead to death. Past attempts to develop tools to help community doctors prescribe medications in a safer manner and to help health care professionals identify and treat adverse drug reactions have not been very successful. This is because the resources required to make the diagnosis and readjust the medications are often not available in the outpatient setting. The ED is the ideal setting to address these problems. EDs have all the necessary resources, and patients with the most severe adverse drug reactions frequently go to the ED. In a previous study, we developed a user-friendly screening tool, similar to a checklist, that accurately identifies patients in the ED with adverse drug reactions. Our goal is to evaluate this screening tool on a larger scale to confirm its safety and accuracy. We propose to do this in a study enrolling 3550 patients from seven EDs in three provinces. Nurses will apply the screening tool we will evaluate, and pharmacists will assess all patients to determine who has an adverse drug reaction. We will then determine how many patients diagnosed with adverse drug reactions the screening tool has detected, how easy it is to use, how reliable it is, and what its potential impact is on clinical practice. Once we have evaluated the screening tool, we plan to roll out it out in EDs throughout Canada and internationally. We believe that this will lead to better patient care, less patient suffering and decrease the cost of health care.
Competitiondate
201109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Hohl, Corinne M
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~